Residual Neuromuscular Blockade
17
0
0
14
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
11.8%
2 terminated out of 17 trials
87.5%
+1.0% vs benchmark
12%
2 trials in Phase 3/4
43%
6 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (17)
Cardiac Output and Recovery Time
Neuromuscular Blockade Monitoring Using Kine-myography vs Electromyography.
Thumb vs Great Toe Recovery
Observational Study in Bariatric Surgery
Electromyographic and Acceleromyographic Monitoring in Restricted Arm Movement Surgical Setting
Visual and Electromyography Assessments in Response to Train-of-Four Stimulation of the Ulnar Nerve
Residual Neuromuscular Blockade in Cardiac Surgery Patients
Incidence of Postoperative Residual Neuromuscular Blockade in Portugal
Comparison of the ToFscan and TetraGraph During Recovery of Neuromuscular Function in the Post Anesthesia Care Unit
Validation of the REPS Prediction Tool
Reversal of Neuromuscular Blockade in Thoracic Surgical Patients
Electromyographic Assessment of Onset and Recovery of Neuromuscular Blockade
Incidence and Severity of Residual Neuromuscular Blockade
Residual Neuromuscular Blockade in Pediatric Anesthesia
Incidence of Postoperative Neuromuscular Blockade in Post-Anesthesia Care Unit at Parkland Hospital: Does Size Matter?
Predictor of Residual Neuromuscular Blockade in Recovery Room After General Anesthesia
Effect of Calcium Chloride on Recovery From Neuromuscular Blockade